Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Good Copper, Bad Copper: News on this Metal's Role in Alzheimer's
15 January 2002. Though considerable effort has been spent over the last few decades investigating the relationship between Alzheimer's disease and aluminum, the role of the transition metal remains controversial. Today, evidence presented in the Journal of Neuroscience strengthens the case for the involvement of a different metal, copper, in the etiology of AD.

An international team of researchers, led by Roberto Cappai, University of Melbourne, challenged cultures of cortical neurons with copper-bound full-length amyloid precursor protein (AβPP), or metallated fragments of the protein, and found a dose-dependent relationship between the amount of added protein-Cu and cell death. Furthermore, the neurotoxicity of AβPP-Cu was dramatically enhanced by low-density lipoprotein (LDL); in its presence, more than twice the number of cells died upon exposure to fivefold less AβPP-Cu.

The authors localized the toxic property of AβPP to amino acids 124-189, which contain the copper-binding domain. This fragment induced cell death and oxidation of LDL when bound to copper. They also found that not all APPs are equally potent. Most toxic were isoforms that contain histidines 147 and 151, which are proposed to chelate the copper atom, while isoforms with one histidine are inert, and those with the histidines replaced by tyrosine and lysine (for example C. elegans APL-1) can actually protect cells against copper-mediated damage.

"This is a very interesting paper that continues to build on the idea that amyloid can bind copper and takes us a step further toward understanding the mechanism of amyloid toxicity and oxidative damage," comments James Connor, Penn State University. However, he cautions that the role of copper may be quite complex. In Menke's and other diseases where copper levels are substantially elevated, no evidence for accelerated dementia has been found.-Tom Fagan.

Reference:White AR, Multhaup G, Galatis D, McKinstry WJ, Parker MW, Pipkorn R, Beyreuther K, Masters CL, Cappai R. Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein. J Neurosci 2002 January 15;22(2):365-376. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad